FDA applicant

Otsuka Pharmaceutical Co., Ltd.

North Attleboro, MA6 decisions1999–20101 recall

FDA records 6 decisions for Otsuka Pharmaceutical Co., Ltd. (North Attleboro, MA) from 1999 to 2010: 6 510(k) clearances. Most are in product codes CHH (Enzymatic Esterase--Oxidase, Cholesterol) and MSQ (Test, Urea (Breath Or Blood)). Its devices cite 9 predicates, 2 of them its own earlier devices. 1 recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, clinical chemistry panel, where it files most

How often FDA has decided Otsuka Pharmaceutical Co., Ltd.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2010

2007high 1 (2010) · low 0 (2007)2026

2026 so far, outlined.

Recalls per year

1in 2008

2007high 1 (2008) · low 0 (2007)2026

Class I Class II/III not classified

FIG. 1 — Otsuka Pharmaceutical Co., Ltd. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Otsuka Pharmaceutical Co., Ltd.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Otsuka”

FDA records each applicant name separately; these may or may not be the same firm.

Otsuka America Pharmaceutical, Inc. 3 Otsuka Electronics USA, Inc. 2 Otsuka Electronics 2

Otsuka Pharmaceutical Co., Ltd.

Which product codes does it file in?

Whose devices does it build on?

Who builds on its devices?

Which of its devices are cited most?

What has FDA decided for it lately?

What has been recalled?

Other applicant names beginning “Otsuka”